CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- 4 Grant or award VP and Chief Culture Officer acquired 2,330 shares (grant or award)
- 4 Grant or award General Counsel acquired 2,912 shares (grant or award)
- 4 Grant or award President, Pharma Services acquired 7,571 shares (grant or award)
- 4 Grant or award President, Clinical Services acquired 8,736 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 5,824 shares (grant or award)
- 4 Grant or award Chairman and CEO acquired 34,945 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 5,824 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
- 4 Open-market sale Chief Accounting Officer sold 8,000 shares at $26.37 ($210,960)
- 4/A Insider Changes in Ownership
- 4 Open-market sale Director sold 151,230 shares at an average $24.34 ($3,680,598)
- 4 Open-market sale Chairman and CEO sold 187,500 shares at $24.08 ($4,515,000)
- 4 Open-market sale VP and Chief Culture Officer sold 6,833 shares at $23.45 ($160,234)
- 4 Open-market sale President, Pharma Services sold 19,444 shares at $23.15 ($450,129)
- 4 Exercise or conversion Chairman and CEO acquired 472,527 shares (option exercise)
- 4 Open-market sale President, Pharma Services sold 55,556 shares at an average $22.82 ($1,267,708)
- 4 Exercise or conversion Director acquired 24,683 shares (option exercise)
- 4 Open-market sale President, Clinical Services sold 106,274 shares at an average $22.99 ($2,442,746)
- 4 Exercise or conversion Director acquired 11,666 shares (option exercise)
Page 16 of 30 · 589 filings